| Literature DB >> 28380394 |
Wei Wei1, Qi Liu2, Zhen-Zhen Li3, Wei-Kang Shi2, Xing Fu2, Jia Liu2, Xuan Zhu2, Xiao-Cong Wang2, Ning Xu2, Teng-Fei Li2, Fu-Rui Jiang2, Zhu-Ping Xiao4, Hai-Liang Zhu5.
Abstract
Tyrosyl-tRNA synthetase (TyrRS) is an aminoacyl-tRNA synthetase family protein that possesses an essential role in bacterial protein synthesis. The synthesis, structure-activity relationship, and evolution of a novel series of adenosine-containing 3-arylfuran-2(5H)-ones as TyrRS inhibitors are described. Advanced compound d3 from this series exhibited excellent affinity for TyrRS with IC50 of 0.61 ± 0.04 μM. Bacterial growth inhibition assays demonstrated that d3 showed submicromolar antibacterial potency against Escherichia coli and Pseudomonas aeruginosa, and compared to the marketed antibiotics ciprofloxacin.Entities:
Keywords: 3-Arylfuran-2(5H)-one; Adenosine; Antibacterial; Molecular docking; Tyrosyl-tRNA synthetase inhibitors
Mesh:
Substances:
Year: 2017 PMID: 28380394 DOI: 10.1016/j.ejmech.2017.03.074
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514